Biosimilars And Beyond: Celltrion Aiming For $9bn Post Merger

After years of talks, Korea's Celltrion Group is finally moving ahead with the merger of three key affiliates aimed at improving cost competitiveness and securing investment resources, as well as simplifying transaction structures and improving governance.